Jan. 26, 2022
#42 - AI technology is changing pathology for precision oncology - with Ori Zelichov from Nucleai
Ori Zelichov M.D. is the VP Clinical Development of Nucleai, a startup company developing image analysis technologies for precision oncology. Dr. Zelichov leads the medical strategy and clinical development for the company. Prior to joining Nucleai, Ori was the Medical Director for Novellus, where he led to the development of a novel targeted treatments for cancer, now being tested in clinical trials.
We talked about product development, the company evolution to match market needs, the 'mom' dilemma and so much more.
Want to continue the conversation? Join our mAcademia Group on facebook.
Music credits: Funkorama Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0 License http://creativecommons.org/licenses/by/3.0/
Send in a voice message: https://anchor.fm/macademia/message